SCHEMBL14336554

SCHEMBL14336554

CCn1c(C(C)(C)C)nc2ncccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.41
NPY5R Q15761 1/20 0.40
BACE1 P56817 1/20 0.38
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 3/20 0.37
CYP1A2 P05177 4/20 0.37
CYP2D6 P10635 2/20 0.37
HTT P42858 1/20 0.37
KDM4E B2RXH2 3/20 0.36
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 1/20 0.35
ATM Q13315 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3450751 0.87 S1PR1 (0.39) S1PR1NPY5RBACE1ALDH1A1KMT2A
SCHEMBL6489159 0.79 HTR3E (0.40) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL6489152 0.78 BACE1 (0.39) BACE1KMT2ACYP1A2CYP2D6KDM4E
SCHEMBL25171851 0.76 CYP1A2 (0.59) S1PR1NPY5RBACE1ALDH1A1KMT2A
SCHEMBL22090002 0.76 KMT2A (0.42) S1PR1NPY5RBACE1ALDH1A1KMT2A
SCHEMBL7762123 0.76 HTT (0.59) ALDH1A1KMT2ACYP1A2CYP2D6HTT
Hydrochloric Acid SCHEMBL31258765 0.75 CYP1A2 (0.57) S1PR1NPY5RBACE1ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL25167011 0.75 CYP1A2 (0.57) S1PR1NPY5RBACE1ALDH1A1KMT2A
SCHEMBL15746018 0.74 BACE1 (0.42) BACE1ALDH1A1KMT2ACYP1A2CYP2D6
SCHEMBL10041264 0.73 BACE1 (0.35) BACE1ALDH1A1KMT2ACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312229-B2 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators MERCK & CO., INC. (US) 2007-12-25 US disclosed
US-20070088047-A1 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators MERCK SHARP & DOHME CORP. 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088047-A1 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators NR5A1, AR, NR3C1 S1PR1 1081/4885NPY5R 2747/4885BACE1 736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.